.png)

TL;DR: Show investors a stage-weighted, ICP-segmented pipeline package tied to your next-quarter revenue target.
Growth equity analysts at Series B use pipeline coverage as a forward revenue stress test, applied before a term sheet is issued. ICONIQ Growth's State of Go-to-Market in 2025 survey of 205 B2B SaaS companies found that average unweighted pipeline coverage per account executive declined from 3.9x in 2024 to 3.6x in 2025, per the State of Go-to-Market in 2025. Growth equity analysts use that observed range as a reference point when stress-testing a founder's forward ARR assumption. A coverage ratio that fails segmentation by stage, ICP fit, and deal velocity signals that the forecast carries structural risk, and analysts price that risk directly into valuation.
Pipeline coverage is the ratio of qualified pipeline value to the revenue target for a defined period. At Series B, analysts examine it at the deal level, the segment level, and the ICP level. A segmented, stage-weighted view gives analysts the structural evidence the aggregate ratio alone cannot provide.
Founders who arrive at a Series B meeting with a pipeline deck built for a sales review face a predictable outcome. The analyst applies a forecast credibility discount, and that discount compounds into a lower valuation or a longer close timeline.
This guide covers the ratios analysts expect, how to build and present a segmented pipeline package, and how coverage interacts with your ARR growth assumptions and what growth equity investors require at Series B.
Pipeline coverage is a forward-looking ratio. It compares the total value of qualified deals in your pipeline to the revenue you need to close in a given period. At the most basic level, a 3x coverage ratio means you have three dollars of qualified pipeline for every one dollar of revenue target.
Growth equity analysts use this ratio for a specific purpose at Series B: they are underwriting a growth assumption, and they need evidence that the assumption is achievable from the pipeline that exists today. Growth equity analysts use the observed ICONIQ averages as a reference point when stress-testing a forward ARR assumption alongside net revenue retention and new logo velocity.
The analyst's core question is structural: does the pipeline contain enough qualified, stage-appropriate deals to absorb normal close-rate variance and still deliver the ARR number?
Three factors determine whether your coverage ratio answers that question:
The Capital Raise Pre-Flight is IRC Partners' fixed-fee diagnostic that scores a raise against the same twelve institutional gates a deal must clear before IRC Partners takes it into a strategic partnership.
Coverage ratio expectations scale with ARR and growth stage. A company at $10M ARR growing at 80% year-over-year faces a different pipeline math problem than one at $28M ARR growing at 40%. Analysts calibrate expectations accordingly.
ICONIQ Growth's State of Go-to-Market in 2025 survey of 205 B2B SaaS companies measures pipeline coverage as unweighted pipeline per account executive, segmented by growth motion. The observed averages in that dataset give analysts a motion-specific reference point when evaluating a founder's forward ARR assumption.
These figures reflect unweighted pipeline, as stated in the ICONIQ published report. Growth equity analysts use the observed average for a founder's growth motion as a reference point. A founder presenting weighted, segmented pipeline coverage below the observed average for their motion gives analysts a credibility gap to price into the valuation.
Bessemer Venture Partners' GTM benchmarks establish that companies growing above 60% year-over-year face a compressed forecast window: a large share of the annual target closes in the first two quarters. Pipeline coverage must match that window to sustain forecast credibility with analysts underwriting the growth assumption.
The practical implication: if your weighted pipeline coverage drops below 3x against the next-quarter revenue target, analysts will model a downside scenario against your growth assumption before the first partner meeting, per ICONIQ Growth's published GTM benchmarks.
Pipeline coverage sits inside a growth equity diligence model alongside two other variables: your ARR growth assumption and your burn multiple.
Your ARR growth assumption implies a new ARR target for the next 12 months. Analysts divide that target by your historical close rates to derive the pipeline they expect you to need. If your weighted pipeline coverage falls short of that derived requirement, the growth assumption loses credibility.
ICONIQ Growth's published GTM benchmarks show that observed unweighted pipeline coverage per account executive varies by growth motion: PLG companies average 3.2x, Hybrid companies average 3.7x, and SLG companies average 3.5x, per the State of Go-to-Market in 2025. Analysts use the observed average for a founder's growth motion as the reference point when stress-testing a forward ARR assumption.
Burn multiple is the dollars of net burn required to generate one dollar of net new ARR. According to Bessemer Venture Partners' benchmarks, a burn multiple above 2x at Series B raises underwriting risk. Analysts who see a high burn multiple alongside a thin pipeline coverage ratio face a compounding credibility problem: the company is burning efficiently only if the pipeline closes, and the pipeline coverage does not support that confidence.
The connection is direct: a pipeline coverage ratio below the institutional floor, combined with a burn multiple above 1.5x, according to Bessemer benchmarks, produces a scenario where analysts model a capital efficiency shortfall into the valuation.
Founders preparing for Series B should review how their founder equity position and financial metrics interact before outreach begins.
The goal of a pipeline presentation package at Series B is to answer the analyst's coverage question before they ask it. A package that forces the analyst to calculate coverage ratios from a raw export is a package that invites skepticism.
A presentation-ready pipeline coverage package contains five components:
Deliver the package as a structured exhibit, separate from your pitch deck. According to ICONIQ Growth's operator guidance, pipeline data presented as an appendix slide inside a pitch deck carries less analytical weight than a standalone exhibit delivered before or alongside the deck.
Analysts treat a standalone, structured pipeline exhibit as a signal of forecast maturity. It demonstrates that the founder understands the difference between a sales review and a diligence review.
Founders who have completed investor readiness preparation before outreach arrive with this package already built.
Growth equity analysts apply a general floor of 3x coverage against the next-quarter revenue target when evaluating Series B forecast credibility. ICONIQ Growth's State of Go-to-Market in 2025 survey of 205 B2B SaaS companies found that observed unweighted pipeline coverage per account executive averaged 3.6x in 2025 and 3.9x in 2024, per the published report. Analysts receiving a raw unweighted number apply conservative internal stage weights that the founder has no visibility into. Companies growing above 50% year-over-year are expected to show 4x or above on a weighted basis, per the same ICONIQ Growth dataset. Analysts who see weighted coverage below 3x apply a forecast credibility discount before the first partner meeting.
Analysts apply their own stage close-rate assumptions to your raw pipeline data. ICONIQ Growth's published GTM benchmarks measure pipeline coverage as unweighted pipeline per account executive, which means analysts receiving a raw number apply conservative internal weights that the founder has no visibility into. Presenting your own stage-weighted calculation, built from at least 12 months of historical win-rate data, gives analysts a verifiable input and removes the need for them to substitute their own assumptions.
Growth equity analysts segment ICP and out-of-ICP pipeline before applying coverage ratios. Out-of-ICP deals carry lower close rates and longer sales cycles than confirmed ICP deals. Analysts weight them at a steep discount or exclude them from the coverage calculation entirely. A coverage ratio that relies on out-of-ICP deals to reach the institutional floor will fail the segmentation review in diligence.
Deals that have stalled past their median stage duration carry a higher implied loss rate. Analysts apply an additional discount to stalled deals when calculating effective weighted coverage. Flagging these deals proactively in your pipeline package removes the diligence friction of the analyst finding them independently.
Bessemer Venture Partners' State of the Cloud benchmarks classify a burn multiple of 2x to 3x at Series B as high and in need of improvement, with above 3x classified as unsustainable, per the Cloud 100 Benchmarks Report. When analysts see a burn multiple at or above the Series B median range of 1.5x to 2.0x, per Bessemer Venture Partners, alongside weighted pipeline coverage below the institutional floor, they model a capital efficiency shortfall into the valuation. The two metrics are linked: high burn is defensible if pipeline coverage supports the growth assumption, and thin coverage converts that burn into a valuation problem.
Institutional investors expect pipeline data that reflects at least two full quarters of stage-level history. Building the coverage package requires a minimum of 12 months of historical win-rate data by stage, per ICONIQ Growth's operator guidance. Founders who begin pipeline documentation at least two full quarters before outreach arrive with the historical depth analysts require.
A ramping product line requires separate treatment in the pipeline package. According to Bessemer Venture Partners' growth benchmarks, analysts evaluate ramping segments against a different coverage floor because historical close-rate data is limited. Present the ramping segment separately, disclose the data depth available, and apply conservative stage weights. Blending a ramping segment into the core pipeline without disclosure is a diligence flag that surfaces in the first analytical review.
The structure you carry into your first investor meeting sets the terms for every round that follows it. Founders who get it wrong spend the next three rounds negotiating from behind. The Capital Raise Pre-Flight is IRC Partners’ fixed-fee diagnostic that scores a raise against the same twelve institutional gates a deal must clear before IRC Partners takes it into a strategic partnership. IRC Partners advises operators raising $5M to $250M of institutional capital. Book your Capital Raise Pre-Flight here.
You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.
We onboard a maximum of seven
new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.